83 related articles for article (PubMed ID: 1881678)
1. [Detection of extended broad-spectrum beta-lactamases with the ATB MIC system].
Ronco E; Migueres ML; Guenounou M; Philippon A
Pathol Biol (Paris); 1991 May; 39(5):480-5. PubMed ID: 1881678
[TBL] [Abstract][Full Text] [Related]
2. Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria.
Lavigne JP; Bonnet R; Michaux-Charachon S; Jourdan J; Caillon J; Sotto A
J Antimicrob Chemother; 2004 Apr; 53(4):616-9. PubMed ID: 14985275
[TBL] [Abstract][Full Text] [Related]
3. [Broad spectrum beta-lactamases and the API ATB 244 system: the need for detection].
Ronco E; Migueres ML; Guenounou M; Philippon A
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):549-52. PubMed ID: 2677926
[TBL] [Abstract][Full Text] [Related]
4. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
[TBL] [Abstract][Full Text] [Related]
5. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
[TBL] [Abstract][Full Text] [Related]
7. Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.
Buijs J; Dofferhoff AS; Mouton JW; Wagenvoort JH; van der Meer JW
Clin Microbiol Infect; 2008 Apr; 14(4):344-9. PubMed ID: 18261128
[TBL] [Abstract][Full Text] [Related]
8. Role of beta-lactamase inhibitors in enterobacterial isolates producing extended-spectrum beta-lactamases.
Bhattacharjee A; Sen MR; Prakash P; Anupurba S
J Antimicrob Chemother; 2008 Feb; 61(2):309-14. PubMed ID: 18174199
[TBL] [Abstract][Full Text] [Related]
9. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
Chin NX; Neu HC
Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967
[TBL] [Abstract][Full Text] [Related]
11. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
Walther-Rasmussen J; Høiby N
Can J Microbiol; 2004 Mar; 50(3):137-65. PubMed ID: 15105882
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of beta-lactam antibiotics in combination with sulbactam against enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter. Results of a multicenter study].
Kazmierczak A; Siebor E; Acar JF; Denis F; Drugeon H; Fleurette J; Sirot J; Soussy CJ; Thabaut A
Pathol Biol (Paris); 1991 May; 39(5):384-90. PubMed ID: 1909015
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
14. [Effect of inoculum size on sensitivity and specificity of the double-disk synergy test for the detection of wide-spectrum beta-lactamases].
Bedenić B; Boras A
Lijec Vjesn; 2001; 123(11-12):293-6. PubMed ID: 11930754
[TBL] [Abstract][Full Text] [Related]
15. The use of antibiotic-containing agars for the isolation of extended-spectrum beta-lactamase-producing organisms in intensive care units.
Wilson G; McCabe D
Clin Microbiol Infect; 2007 Apr; 13(4):451-3. PubMed ID: 17359334
[TBL] [Abstract][Full Text] [Related]
16. [Effect of ceftazidime on enterobacteria and Pseudomonas producers of beta-lactamases].
Chabbert YA; Derlot E; Courvalin P
Pathol Biol (Paris); 1985 Sep; 33(7):758-63. PubMed ID: 3936006
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
Pottumarthy S; Yu Y; Sader HS; Jones RN; Chen M
Diagn Microbiol Infect Dis; 2005 Oct; 53(2):131-41. PubMed ID: 15939566
[TBL] [Abstract][Full Text] [Related]
18. Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of beta-lactamase-producing Enterobacteriaceae.
Siu LK; Cheng WL; Ho PL; Ng WS; Chau PY; Lo JY
APMIS; 1998 Sep; 106(9):917-20. PubMed ID: 9808419
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
Schmalreck AF; Wildfeuer A
Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
[TBL] [Abstract][Full Text] [Related]
20. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
